Histogen Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today presented findings from preliminary evaluations of the Company's HGEN-001 formulation, during International Investigative Dermatology 2008, taking place May 14-17, 2008 in Kyoto, Japan. ... more
Tags: formulation, hgen, evaluations, company,

Keywords: Dermatology news, medical news, health news, medical headlines, healthcare news, health articles, medicine articles, welfare, living

Description: Histogen Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today presented findings from preliminary evaluations of the Company's HGEN-001 f